Cargando…
A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients
BACKGROUND: COVID-19 prediction models based on clinical characteristics, routine biochemistry and imaging, have been developed, but little is known on proteomic markers reflecting the molecular pathophysiology of disease progression. METHODS: The multicentre (six European study sites) Prospective V...
Autores principales: | Wendt, Ralph, Thijs, Lutgarde, Kalbitz, Sven, Mischak, Harald, Siwy, Justyna, Raad, Julia, Metzger, Jochen, Neuhaus, Barbara, Leyen, Heiko von der, Dudoignon, Emmanuel, Mebazaa, Alexandre, Spasovski, Goce, Milenkova, Mimoza, Canevska-Talevska, Aleksandra, Czerwieńska, Beata, Wiecek, Andrzej, Peters, Björn, Nilsson, Åsa, Schwab, Matthias, Rothfuss, Katja, Lübbert, Christoph, Staessen, Jan A., Beige, Joachim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8092440/ https://www.ncbi.nlm.nih.gov/pubmed/33969282 http://dx.doi.org/10.1016/j.eclinm.2021.100883 |
Ejemplares similares
-
Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study
por: Staessen, Jan A, et al.
Publicado: (2022) -
CD99 and polymeric immunoglobulin receptor peptides deregulation in critical COVID‐19: A potential link to molecular pathophysiology?
por: Siwy, Justyna, et al.
Publicado: (2021) -
Urinary peptidomic profiles to address age-related disabilities: a prospective population study
por: Martens, Dries S, et al.
Publicado: (2021) -
Proteomic characterization of obesity-related nephropathy
por: Wendt, Ralph, et al.
Publicado: (2020) -
Recent Advances in Urinary Peptide and Proteomic Biomarkers in Chronic Kidney Disease: A Systematic Review
por: Catanese, Lorenzo, et al.
Publicado: (2023)